Veru Inc (NASDAQ:VERU) released its quarterly earnings data on Tuesday. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.05, Morningstar.com reports. Veru had a negative net margin of 73.86% and a negative return on equity of 20.72%.

Veru (NASDAQ VERU) traded down 10.67% during midday trading on Tuesday, reaching $1.34. 17,037 shares of the company traded hands. Veru has a 12 month low of $1.32 and a 12 month high of $1.45.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/08/veru-inc-nasdaqveru-announces-quarterly-earnings-results-beats-expectations-by-0-05-eps.html.

About Veru

Veru Inc, formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.

Receive News & Ratings for Veru Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru Inc and related companies with MarketBeat.com's FREE daily email newsletter.